chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient began experiencing intense joint, back, and leg pain and weakness, beginning two days after SHINGRIX vaccine (7/4/18). She reported these symptoms to the pharmacy when the pharmacist called to schedule her second SHINGRIX vaccine the middle of September 2018. The pharmacist advised her to contact her physician immediately. She saw Dr on 10/02/18 and was prescribed prednisone 20mg twice daily for 4 days, then once daily for 4 days. She states that her pain has improved as of 10/16/18.
Pt c/o (L) shoulder pain and stiffness starting 2 days after vaccination. After several days, couldn't raise arm above shoulder level. No pain at time of shot. Day after shot had mild soreness (L) arm. Denied pain, swelling at injection site. Resolved with NSAIDS after 10 days.
DEVELOPED MODERATE INFLUENZA SYMPTOMS AS IF I WAS HAVING THE FLU ITSELF WITH FEVER, CHILLS, DIFFUSE MYALGIAS, SORE THROAT AND NASAL CONGESTION WITHIN 24 HOURS OF RECEIVING THE LIVE INTRANASAL INFLUENZA VACCINE.  THIS INCLUDED HEADACHE.  THE FOLLOWING DAY, SYMPTOMS RESOVLED, BUT WERE QUICKLY REPLACED BY UPPER RESPIRATORY INFECTION SYMPTOMS WITHOUT FEVER WHICH LASTED FOR 10 DAYS.  THESE INCLUDED RHINORRHEA, NASAL AND EAR CONGESTION, OTALGIA, MODERATE HEARING LOSS, LARYNGITIS, CHRONIC DRY COUGH.  ON DAY 7 POST VACCINATION, I WOKE IN THE MIDDLE OF THE NIGHT WITH SIGNIFICANT EPISTAXIS WHICH TOOK NEARLY 5 HOURS TO STAUNCH.  ALTHOUGH I DID NOT SEEK MEDICAL TREATMENT, MY IMPRESSION WAS THAT THE BLEEDING WAS POSTERIOR AND STOPPED OF ITS OWN ACCORD EVENTUALLY.  MILDER INTERMITTENT EPISTAXIS PERSISTED FOR 4 DAYS.  I DO NOT KNOW WHAT TOTAL BLOOD LOSS WAS OR IF I DEVELOPED AN ANEMIA AS A RESULT.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 74-year-old female patient who received SHINGRIX (batch number NX952, expiry date 6th March 2020). Concomitant products included oxybutynin. On 13th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 15th April 2018, 2 days after receiving SHINGRIX, the patient experienced injection site erythema, injection site muscle pain and injection site swelling. On an unknown  date, the outcome of the injection site erythema, injection site muscle pain and injection site welling were not recovered/not resolved. The reporter considered the injection site erythema, injection site muscle pain and injection site swelling to be probably related to SHINGRIX. Additional details were provided as follows: On 13th April 2018 at 15:10 hours, the patient received SHINGRIX on left arm. The patient experienced redness, swelling and muscle pain around the injection site. The reporter thought that, on 15th April 2018, the symptoms were started. On 16th April 2018, the patient was seen at pharmacy and at the time she visited, the symptoms were getting worse. There was no itching.
admitted for COVID-19 pneumonia.the patient is requiring 2 L of oxygen via nasal cannula, and is tachypneic with respiratory rate above 30, patient will benefit from remdesivir
Local redness and itching noted after KINRIX and varicella vaccine. First noted by parent 8/5/13 vaccine given 8/2/13. Reaction 3 in x 3 in (L) arm.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAC (lot# was not reported). On an unknown date the patient experienced developed a rash post vaccination. The patient sought medical attention. The outcome of developed a rash post vaccination was unknown. Additional information has been requested.
#COVID-19 pneumonia  #Acute Hypoxemic Respiratory Failure Patient (vaccinated x2, no booster) with multiple comorbidities that make him high risk including DCM, obesity, and OSA with pHTN. Hypoxic at home ot 88, and on admission as well to 88-89%. Patient has recent COVID contact or recent travel. Bacterial pneumonia was considered given procalcitonin of 0.20, but felt unlikely given chest CT findings showing bilateral ground glass opacities, predominantly in the lingula and left lower lobe. He was started on oral dexamethasone with plan for 10 day total course. He was also started on remdesivir and rapidly improved on 2-4L of O2 by nasal cannula. On the day of discharge, he was satting >94% on room air. With ambulation, he desaturated to 88% but quickly recovered, which the patient attests is his baseline. He was discharged on 12/6 without supplemental home O2. On discharge, remdesivir was stopped and dexamethasone was continued for a full 10 day course.
Scratcy throat, head cold feeling, mild fever, tiredness, swollen nymph nodes in neck
Patient presented to the clinic on 2/22/19 with redness and swelling to right deltoid. Dr. gave verbal order to send patient to ER for further eval and TX.
September 18, 2021, next day after the shot: muscle pain in the right arm, some weakness and numbness in the left arm radiating to the left leg. These symptoms went away by the following day. Starting around September 29, 2021 :  Light symptoms of irregular heartbeat, small palpitations, some numbness and pain in the left arm and leg, overall body weakness. On the night of October 8th, 2021: very bad palpitations overnight kept waking me up on and off. I was sweating, very hot and weak, no fever. In the morning pain in left jaw, radiating to the left shoulder, and left arm, very bad palpitations. I ended up in the ER on stroke alerts. Was discharged after brain MRI and CT scan and no stroke confirmed. I spent all day in bed, was too weak to do anything, called off work. Spent the next day in bed as well. Starting with the October 9, 2021 up to today I am unable to work and keep having the following symptoms: I feel very tired and have to lay down and rest after every small activity I do, like walking or doing dishes. I keep having fast, fluttering and pounding heart beat that comes and goes often. When it comes I get extremely weak and have shortness of breath and have to lay down. It seems like my heart is working very hard. The left side of my body: jaw, neck, shoulder (top and back), arm and leg still hurt and I have numbness and tingling in my face, fingers and now toes. It seems that has intensified since the last time I saw my MD. In addition to that constant pain that I have all the time, I also get sporadic pain that seems to come in painful waves in muscles and joints. I spent the last week laying down most of the time feeling very tired. Just over a month ago, before I got the Covid19 shot, I was doing four mile bike rides, in the hot day, and I was perfectly fine. Today I can?t even go to work.  To summarize I have the following: - I get tired very easily - I get weak and have to lay down - Heart palpitations - Weakness in left arm and leg - Pain in left arm and leg - Pain in left shoulder - Occasional pain in left jaw especially during fast, pounding heart beat - Some numbness on left side of face and neck - Tingling and numbness in middle fingers of left hand and toes of left foot - Shortness of breath during heart palpitations - Heaviness and pain around my heart during palpitations - Feeling shaky - It seems like my heart has to work very hard - Delayed coordination in left hand and arm, some in left leg  MRI of neck and shoulder was ordered by Dr. but was denied by insurance. Physical therapy was approved. B12 vitamin shots were started for low B12 (235).  First available appointment for physical therapy is scheduled for November 4, 2021. First available appointment with cardiologist is scheduled for November 16, 2021. First available appointment with Neurologist is scheduled for December 23, 2021.
bulging of veins on her both feet, both hands and on right side of forehead and it is still there; soreness of left arm; Body ache; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VEIN DISORDER (bulging of veins on her both feet, both hands and on right side of forehead and it is still there), PAIN IN EXTREMITY (soreness of left arm), MYALGIA (Body ache), PYREXIA (Fever) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 002C21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure since 01-May-2006. Concomitant products included AMLODIPINE for Blood pressure.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced PAIN IN EXTREMITY (soreness of left arm), MYALGIA (Body ache), PYREXIA (Fever) and CHILLS (Chills). On 12-Jun-2021, the patient experienced VEIN DISORDER (bulging of veins on her both feet, both hands and on right side of forehead and it is still there). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 500 mg. At the time of the report, VEIN DISORDER (bulging of veins on her both feet, both hands and on right side of forehead and it is still there) had not resolved and PAIN IN EXTREMITY (soreness of left arm), MYALGIA (Body ache), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jun-2021, Body temperature: 39.2 (abnormal) 39.2 degree Celsius.         This case was linked to MOD-2021-221001 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow-up information received contains patient's race, height and weight, Lot number.
Nerve tingling after shot felt in lower left-back. Ill with a headache for a day or two. The week after the shot felt uncomfortable but better until the following week started. A sharp pain was felt under the underarm area. The pain increased. I tried Motrin to help, but it still persisted. Used ice pack to help decrease irritation but only helped a little. Made an appointment in Jan to be seen. After being checked, I was told to continue with a higher dose of ibuprofen and to have an ultrasound with my breast specialist. The area was felt for swollen lymph nodes. None was found at the time. The doctor felt it was an adverse result from the booster and most likely need time to heal.
Patient described sxs starting about 1 week after vaccinations. She had numbness in her leg/back. Patient was seen by PCP given pain meds hydrocodone/APAP, Diclofenac.
Developed localized itching 2 hours after vaccination. Applied ice, hydrocortisone cream with some improvement. Took BENADRYL 10/25, 26 and 27. 10/28 erythema (sm amt) persists with itching. 11-1-13 did add OTC dermatitis cream during day vs BENADRYL small bump left - but resolving.
No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced ADVERSE EVENT (standard side effects), PAIN (achy), BODY TEMPERATURE DECREASED (low temperature), FATIGUE (tired), CHILLS (chills that shook his body), PYREXIA (feverish feeling) and ARTHRALGIA (achy joints). On 02-Mar-2021, ADVERSE EVENT (standard side effects), PAIN (achy), BODY TEMPERATURE DECREASED (low temperature), FATIGUE (tired), CHILLS (chills that shook his body), PYREXIA (feverish feeling) and ARTHRALGIA (achy joints) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.    Reporter did not allow further contact
vaccine was kept in refrigerator on 03 Nov 2021 and administered on 11 Oct 2021; 606 doses were given after expiration date / vaccine was kept in refrigerator on 03 Nov 2021 and expired on 9 Oct 2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date / vaccine was kept in refrigerator on 03 Nov 2021 and expired on 9 Oct 2021) and PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 03 Nov 2021 and administered on 11 Oct 2021) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date / vaccine was kept in refrigerator on 03 Nov 2021 and expired on 9 Oct 2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 03 Nov 2021 and administered on 11 Oct 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date / vaccine was kept in refrigerator on 03 Nov 2021 and expired on 9 Oct 2021) and PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 03 Nov 2021 and administered on 11 Oct 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.  No temperature excursion of the product reported. No adverse event experienced by the patient.
Pt reports myalgia and muscle weakness which last approx. 1 week post vaccination, reports that he  had similar reactions with prior 2 doses but this one is worse.
Patient became lightheadness and nausea after receiving Human Rabies Immunoglobulin (HRIG) HyperRAB lot#26NJR01 exp 12 Jun 2013. Patient received 13 mL (milliliters) dosed by weight of 215 pounds. Patient received dose intramuscularly with 23 gauge needle given by nurse. Medication dispersed in right deltoid, right and left anterolateral thigh. Patient also received rabies vaccine, 1 milliliter IM, RabAvert Lot#49011A exp June 2015 to L deltoid. After event, I physician immediately at bedside and blood pressure 120/80. Symptoms resolved within 2-3 minutes. Patient received Rabies VIS (Vaccine Administration Sheet) and verbal informed consent was obtained prior to vaccine administration. Patient instructed to report immediately to Emergency Department for difficulty breathing, wheezing, itching at back of the throat, hives, worsening of symptoms, change in level of consciousness.
Starting 72 hours after my first vaccine, I experienced severe flu symptoms: all-over body aches, 102-103 degree fever, nausea, some vomiting. These severe symptoms persisted for 72 more hours. I could not sleep due to the pain at times - Tylenol did nothing. The all-over body aches did not go away. My second injection was identical to the first in that I suffered high fever, nausea, vomiting and body ache. The ache subsided after about a week, but it was still present, especially when certain pressure points were pressed, often times for no reason at all in my hands, feet, back, legs and neck. Please see Item 19 for diagnosis and current symptoms.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium
11/13/2008 phone call from mother concerned about swollen, red arm.  Ice was applied to site.  Area red/swollen on lower part of arm 11/14/08 mom states area of redness reduced to size of golf ball now.
This patient tested positive for Covid-19 via home test on 23May2022; This patient tested positive for Covid-19 via home test on 23May2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Lot number: 5318), in left arm, on 20Apr2021 as dose 2, single (Lot number: 5318), in left arm and on 16Dec2021 as dose 3 (booster), single (Lot number: 2589) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sulfa" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 23May2022, outcome "recovered" and all described as "This patient tested positive for Covid-19 via home test on 23May2022". The patient underwent the following laboratory tests and procedures: Nasal abscess: (23May2022) Positive, notes: Covid 19 via home test. Therapeutic measures were not taken as a result of drug ineffective, covid-19.
Broke out with big red spots on my body. My right arm had two red marks - raised like a blister type - not fluid from them but the mass, spread - now it's scarred (R arm). Red dots on my body and black and blue for no reason. Still having problems.
Approximately 10-15 minutes after 2nd dose of Pfizer vaccine, patient reported scattered itching without hives over neck, elbows, legs. No dyspnea/wheezing.   + h/o SAR and unclear food allergy, but no Asthma/atopy.
This case was reported by a physician via sales rep and described the occurrence of erythematous eruption in a female adult patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced erythematous eruption and generalized pruritus. The patient was treated with BENADRYL. On an unknown date, the outcome of the erythematous eruption and generalized pruritus were recovered/resolved. The reporter considered the erythematous eruption and generalized pruritus to be probably related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX at a pharmacy and developed a rash all over her body, followed by itchiness all over the body the next day. Pharmacist advised her to take BENADRYL, and the symptoms cleared up after 2 days. The patient shared the information with her allergist (reporting physician) who relayed the information to GlaxoSmithKline. The physician would likely recommend that the patient should not receive the 2nd dose of SHINGRIX. It was unknown if the course of vaccination was discontinued. This case was not associated with any of the seriousness criteria.
Chills, fever (100.7), bad headache, weakness, queasy stomach, vomiting (1x), lack of appetite.  Fever broke after 2 days, headache lasted 3 days, weakness remained for 5 days, strength improved more each day after that.  Returned to work 7 days after vaccination.  Appetite returned slowly after 2 days of little to no eating, seems to have normalized now at 2 weeks since vaccination.
Initial unsolicited pregnancy report received from a healthcare professional on 07 April 2015. A 47-year-old female patient (age not reported), whose concomitant medication were not reported, had received intramuscularly a dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (ADACEL) (batch number: C4714AA, expiry date: 08 April 2017) (cycle in series, number of dose and site of vaccination were not reported) on 06 April 2015. On an unspecified date vaccine exposure during pregnancy was reported with no adverse event. Medical history of the patient was reported as hypertension and was previously a smoker. Last menstrual periods was reported as 05 June 2014. Estimated date of delivery was reported as 12 April 2014. Treatment for infertility was reported as unknown. List of documents held by sender: none.
On February 6 noticed Pain over the right ear and next day pain was going towards the mandibular angle. On Monday the 8th of February I was seen by Dr.  ENT specialist ,I was checked .He confirmed Bell's Palsy He prescribed  Prednisone 20MG for 15 days and Valacyclovir  twice daily for ten days.    .
Patient fainted twice approximately 5 minutes after receiving her COVID-19 vaccination.  No anaphylaxis in evidence, breathing and pulse rate normal.  I observed and comforted the patient until EMS arrived.  EMS checked her blood sugar and blood pressure, both were normal according to them.  At that point, EMS transported the patient to a local hospital for observation and further examination.
Child was given vaccines and waited in room for 5 minutes. Child walked to waiting room where he reported he was feeling nauseated and sat down. Nurse was called and with father's assistance he was escorted to room. Child was placed on table, legs elevated, Blood pressure taken, given popcycle and physician was called. Monitored for 20 minutes. Able to walk out of facility on own
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 03-AUG-2017, the patient was vaccinated with an improperly stored dose of PROQUAD (lot # N000336, expiration date 03-JUL-2018, dose and route not reported) for prophylaxis. The vaccine was improperly stored at 6F to 14 F for 30 minutes. There was no previous temperature excursion. Data logger was involved. The sterile diluent(STERILE DILUENT) used to reconstitute the PROQUAD did not undergo a temperature excursion. No adverse effect was reported.
Dizziness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  No treatment medication were provided.
I had productive cough that got worse over time and would not let up and wheezing.  I hadn't had an asthma symptoms whatsoever since 2003 and had not needed any medications. I finally made an appointment with my doctor  about my symptoms and was prescribed Flovent.  That only gave me marginal relief, so they added Singular.  I am still having the deep, harsh cough about 10 times a day, but it is no longer constant.  I am still having to use my emergency inhaler daily, sometimes twice.  My doctor ordered a chest x-ray and they found a couple of nodules on my lung.  I am having a CT scan with contrast next week.  I have no idea if this is related to the vaccine or note, and am just reporting to do my part to better the science - just another data point.
Intussusception requiring surgical reduction occurred 3/1/08. 03/14/2008 MR received for DOS 3/01-04/2008 with D/C DX:  S/P Exploratory Laparotomy.  Reduction of Intussusception.  Appendectomy.  Infant presented to local hospital with abdominal pain, vomiting and bloody stools. Recent URI. Intussusception noted on abdominal CT and pt transfered to current facility for tx. Air enema unsuccessful at reduction and pt to OR for Ex Lap and reduction of IS.  pt experience post-op fevers.  Taking po on POD#2 and D/C home on POD#3. Seen again in ER 3/5/08 after no BM and fussiness.  Glycerine supp given for constipation.
Sat injection at 10:00 am. 7 pm arm  sore when lifting. 10:00 pm queasy Next am (Sun) dry heaves, sick to stomach, chest felt funny, cold sweats, slept most of day, headache above eyes Mon day 3 lite headache, queasy, sick to stomach, Rash and warm top side of injection arm Tues day 4,  spots towards top/ inside of injected arm , face color yellowish Sick to stomach, sweats, alittle short of breathe,  Wed day 5, little queasy, rash on arm less
8 hours approximately I had extreme chills and body ache. I took an advil to suppress the symptoms, then the next day  I felt so much better.